[Skip to Content]
[Skip to Content Landing]
June 1967

Clotting-Fibrinolysis in a Cavernous Hemangioma

Author Affiliations

New York
From the departments of medicine and obstetrics, Columbia-Presbyterian Medical Center, New York. Dr. Hillman is presently at King County Hospital, University of Washington Medical School, Seattle.

Am J Dis Child. 1967;113(6):649-653. doi:10.1001/archpedi.1967.02090210063003

THE ASSOCIATION of a bleeding tendency with giant cavernous hemangiomas was first noted in 1940 by Kasabach and Merritt.1 Since then approximately 50 additional cases have been reported, of which the majority have had sizeable benign hemangiomas, thrombocytopenia, and a severe bleeding diathesis.2,3 Although many etiologies have been proposed, recently it has been appreciated that more than just platelets are depressed in a typical case. Five or more patients with extensive evaluations have now been shown to have not only thrombocytopenia but also low fibrinogen levels, depressed clotting factors V and VIII, and activation of fibrinolytic systems.4-9 In view of this new evidence the concept of clotting-lysis, a continuous clotting process in the hemangioma with subsequent rapid lysis of the clot, has been introduced. Reversibility of two of the cases by anticoagulation has supported the theory.3,7

To further characterize the clotting-lysis mechanism, we employed tracer doses

First Page Preview View Large
First page PDF preview
First page PDF preview